Objective evaluation of the visibility of colorectal lesions using eye tracking.


Journal

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
ISSN: 1443-1661
Titre abrégé: Dig Endosc
Pays: Australia
ID NLM: 9101419

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 27 12 2018
accepted: 10 03 2019
pubmed: 15 3 2019
medline: 18 2 2020
entrez: 15 3 2019
Statut: ppublish

Résumé

To assess the visibility of colorectal lesions using blue laser imaging (BLI)-bright and linked-color imaging (LCI) with an eye-tracking system. Eleven endoscopists evaluated 90 images of 30 colorectal lesions. The lesions were randomly selected. Three images of each lesion comprised white light imaging (WLI), BLI-bright, and LCI in the same position. Participants gazed at the images, and their eye movements were tracked by the eye tracker. We analyzed whether the participants could detect the lesion and how long they took to detect the lesion. We assessed the miss rate and detection time among the imaging modalities. One endoscopist was excluded, and 10 endoscopists were assessed. Overall, 12.6% of lesions were missed with WLI, 6.0% with BLI-bright, and 4.3% with LCI; the miss rate of BLI-bright and LCI was significantly lower than that of WLI (P < 0.01), with no significant difference between the former modalities (P = 0.54). Mean (± SD) detection times were 1.58 ± 1.60 s for WLI, 1.01 ± 1.21 s for BLI-bright, and 1.10 ± 1.16 s for LCI. Detection time for BLI-bright and LCI was significantly shorter than that for WLI (P < 0.0001), with no significant difference between the former modalities (P = 0.34). Regarding the miss rate and detection time between the expert and the non-experts, there was a significant difference with WLI but not with BLI-bright and LCI. Blue laser imaging-bright and LCI improved the detection of colorectal lesions compared with WLI using an eye-tracking system.

Sections du résumé

BACKGROUND AND AIM OBJECTIVE
To assess the visibility of colorectal lesions using blue laser imaging (BLI)-bright and linked-color imaging (LCI) with an eye-tracking system.
METHODS METHODS
Eleven endoscopists evaluated 90 images of 30 colorectal lesions. The lesions were randomly selected. Three images of each lesion comprised white light imaging (WLI), BLI-bright, and LCI in the same position. Participants gazed at the images, and their eye movements were tracked by the eye tracker. We analyzed whether the participants could detect the lesion and how long they took to detect the lesion. We assessed the miss rate and detection time among the imaging modalities.
RESULTS RESULTS
One endoscopist was excluded, and 10 endoscopists were assessed. Overall, 12.6% of lesions were missed with WLI, 6.0% with BLI-bright, and 4.3% with LCI; the miss rate of BLI-bright and LCI was significantly lower than that of WLI (P < 0.01), with no significant difference between the former modalities (P = 0.54). Mean (± SD) detection times were 1.58 ± 1.60 s for WLI, 1.01 ± 1.21 s for BLI-bright, and 1.10 ± 1.16 s for LCI. Detection time for BLI-bright and LCI was significantly shorter than that for WLI (P < 0.0001), with no significant difference between the former modalities (P = 0.34). Regarding the miss rate and detection time between the expert and the non-experts, there was a significant difference with WLI but not with BLI-bright and LCI.
CONCLUSION CONCLUSIONS
Blue laser imaging-bright and LCI improved the detection of colorectal lesions compared with WLI using an eye-tracking system.

Identifiants

pubmed: 30869814
doi: 10.1111/den.13397
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

552-557

Informations de copyright

© 2019 Japan Gastroenterological Endoscopy Society.

Références

Zauber AG, Winawer SJ, O'Brien MJ et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N. Engl. J. Med. 2012; 366: 687-96.
Rex DK, Cutler CS, Lemmel GT et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112: 24-8.
Postic G, Lewin D, Bickerstaff C, Wallace MB. Colonoscopic miss rates determined by direct comparison of colonoscopy with colon resection specimens. Am. J. Gastroenterol. 2002; 97: 3182-5.
Rex DK, Chadalawada V, Helper DJ. Wide angle colonoscopy with a prototype instrument: impact on miss rates and efficiency as determined by back-to-back colonoscopies. Am. J. Gastroenterol. 2003; 98: 2000-5.
Triadafilopoulos G, Watts HD, Higgins J, Van Dam J. A novel retrograde-viewing auxiliary imaging device (Third Eye Retroscope) improves the detection of simulated polyps in anatomic models of the colon. Gastrointest. Endosc. 2007; 65: 139-44.
Gralnek IM, Carr-Locke DL, Segol O et al. Comparison of standard forward-viewing mode versus ultrawide-viewing mode of a novel colonoscopy platform: a prospective, multicenter study in the detection of simulated polyps in an in vitro colon model (with video). Gastrointest. Endosc. 2013; 77: 472-9.
Osawa H, Yamamoto H. Present and future status of flexible spectral imaging color enhancement and blue laser imaging technology. Dig. Endosc. 2014; 26(Suppl 1): 105-15.
Shimoda R, Sakata Y, Fujise T et al. The adenoma miss rate of blue-laser imaging vs. white-light imaging during colonoscopy: a randomized tandem trial. Endoscopy 2017; 49: 186-90.
Ikematsu H, Sakamoto T, Togashi K et al. Detectability of colorectal neoplastic lesions using a novel endoscopic system with blue laser imaging: a multicenter randomized controlled trial. Gastrointest. Endosc. 2017; 86: 386-94.
Okada M, Sakamoto H, Takezawa T et al. Laterally spreading tumor of the rectum delineated with linked color imaging technology. Clin. Endosc. 2016; 49: 207-8.
Paggi S, Mogavero G, Amato A et al. Linked color imaging reduces the miss rate of neoplastic lesions in the right colon: a randomized tandem colonoscopy study. Endoscopy 2018; 50: 396-402.
Min M, Deng P, Zhang W, Sun X, Liu Y, Nong B. Comparison of linked color imaging and white-light colonoscopy for detection of colorectal polyps: a multicenter, randomized, crossover trial. Gastrointest. Endosc. 2017; 86: 724-30.
Suzuki T, Hara T, Kitagawa Y, et al. Linked-color imaging improves endoscopic visibility of colorectal nongranular flat lesions. Gastrointest. Endosc. 2017; 86: 692-7.
Yoshida N, Naito Y, Murakami T et al. Linked color imaging improves the visibility of colorectal polyps: a video study. Endosc. Int. Open 2017; 5: E518-e25.
Almansa C, Shahid MW, Heckman MG, Preissler S, Wallace MB. Association between visual gaze patterns and adenoma detection rate during colonoscopy: a preliminary investigation. Am. J. Gastroenterol. 2011; 106: 1070-4.
Bertram R, Kaakinen J, Bensch F et al. Eye movements of radiologists reflect expertise in CT study interpretation: a potential tool to measure resident development. Radiology 2016; 281: 805-15.
Meining A, Atasoy S, Chung A, Navab N, Yang GZ. “Eye-tracking” for assessment of image perception in gastrointestinal endoscopy with narrow-band imaging compared with white-light endoscopy. Endoscopy 2010; 42: 652-5.
Sano Y, Chiu HM, Li XB et al. Standards of diagnostic colonoscopy for early-stage neoplasia: recommendations by an Asian private group. Dig. Endosc. 2018. https://doi.org/10.1111/den.13330
Sivanathan V, Tontini GE, Mohler M, Galle PR, Neumann H. Advanced endoscopic imaging for diagnosis of inflammatory bowel diseases: Present and future perspectives. Dig. Endosc. 2018; 30: 441-8.
Kudo S, Kashida H, Tamura T et al. Colonoscopic diagnosis and management of nonpolypoid early colorectal cancer. World J. Surg. 2000; 24: 1081-90.
Tsuda S, Veress B, Toth E, Fork FT. Flat and depressed colorectal tumours in a southern Swedish population: a prospective chromoendoscopic and histopathological study. Gut 2002; 51: 550-5.

Auteurs

Kana Kumahara (K)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Hiroaki Ikematsu (H)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Kensuke Shinmura (K)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Tatsuro Murano (T)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Atsushi Inaba (A)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Kei Okumura (K)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Keiichiro Nishihara (K)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Hironori Sunakawa (H)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Yasuaki Furue (Y)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Renma Ito (R)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Daiki Sato (D)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Tatsunori Minamide (T)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Naoki Okamoto (N)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Yoichi Yamamoto (Y)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Masayuki Suyama (M)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Kenji Takashima (K)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Keiichiro Nakajo (K)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Yusuke Yoda (Y)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Keisuke Hori (K)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Yasuhiro Oono (Y)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Tomonori Yano (T)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH